Fox Run Management L.L.C. lessened its holdings in Maximus, Inc. (NYSE:MMS – Free Report) by 51.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,558 shares of the health services provider’s stock after selling 9,220 shares during the quarter. Fox Run Management L.L.C.’s holdings in Maximus were worth $639,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of MMS. Nordea Investment Management AB bought a new stake in Maximus in the 4th quarter valued at about $4,618,000. Fort Washington Investment Advisors Inc. OH raised its position in shares of Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock valued at $22,132,000 after buying an additional 83,390 shares in the last quarter. IFP Advisors Inc raised its position in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after buying an additional 302 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Maximus in the fourth quarter valued at approximately $1,113,000. Finally, Charles Schwab Investment Management Inc. grew its position in Maximus by 12.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after buying an additional 102,350 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on Maximus
Maximus Stock Performance
Shares of NYSE:MMS opened at $66.48 on Tuesday. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of 14.30 and a beta of 0.71. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company’s 50 day simple moving average is $70.86 and its 200 day simple moving average is $78.31.
Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were issued a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.80%. Maximus’s dividend payout ratio (DPR) is currently 25.81%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
- Five stocks we like better than Maximus
- What is Short Interest? How to Use It
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- The How And Why of Investing in Oil Stocks
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Which Wall Street Analysts are the Most Accurate?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.